FDA OKs Tygacil

The FDA has approved Wyeth Pharmaceuticals' antibiotic Tygacil to treat bacterial infections. The move gives hospitals another weapon in the war against new and disturbingly durable infections, including methicillin-resistant staph aureus, or MRSA, which has spread beyond hospitals and into the community. The new antibiotic is intended to combat a broad range of bacteria. Side effects include nausea and vomiting.

- read this article from the AP for more